Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828886) titled 'Immune Aging and Advanced Therapy Outcomes in Older Adults With IBD' on Sept. 7.
Study Type: Observational [Patient Registry]
Primary Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Condition:
Inflammatory Bowel Disease (Crohn'
s Disease and Ulcerative Colitis)
Frailty
Immunosenescence
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 300
To know more, visit https://clinicaltrials.gov/study/NCT07828886
Published by HT Digital Content Services with permission from Health Daily Digest....